-+ 0.00%
-+ 0.00%
-+ 0.00%

Clearmind Medicine Announces Johns Hopkins Approval For CMND-100 Phase 1/2 Clinical Trial

Benzinga·05/26/2026 12:35:47
Listen to the news

The approval advances the multicenter study titled "A Phase I/II Single and Multiple Dose Tolerability, Safety and Pharmacokinetic Study of CMND-100 in Healthy Volunteers and Alcohol Use Disorder (AUD) Subjects: Parts A, B, and C" and permits the Company to proceed with Parts B and C.